- Home
- BCYC vs JQC Comparison
BCYC vs JQC Comparison
Compare BCYC & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- JQC
- Stock Information
- Founded
- BCYC 2009
- JQC 2003
- Country
- BCYC United Kingdom
- JQC United States
- Employees
- BCYC N/A
- JQC N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- JQC Finance Companies
- Sector
- BCYC Health Care
- JQC Finance
- Exchange
- BCYC Nasdaq
- JQC Nasdaq
- Market Cap
- BCYC 896.2M
- JQC 749.9M
- IPO Year
- BCYC 2019
- JQC N/A
- Fundamental
- Price
- BCYC $11.66
- JQC $5.52
- Analyst Decision
- BCYC Buy
- JQC
- Analyst Count
- BCYC 9
- JQC 0
- Target Price
- BCYC $33.25
- JQC N/A
- AVG Volume (30 Days)
- BCYC 295.8K
- JQC 714.6K
- Earning Date
- BCYC 03-04-2025
- JQC 01-01-0001
- Dividend Yield
- BCYC N/A
- JQC 11.13%
- EPS Growth
- BCYC N/A
- JQC N/A
- EPS
- BCYC N/A
- JQC N/A
- Revenue
- BCYC $36,898,000.00
- JQC N/A
- Revenue This Year
- BCYC $41.07
- JQC N/A
- Revenue Next Year
- BCYC N/A
- JQC N/A
- P/E Ratio
- BCYC N/A
- JQC N/A
- Revenue Growth
- BCYC 48.60
- JQC N/A
- 52 Week Low
- BCYC $11.14
- JQC $4.82
- 52 Week High
- BCYC $28.67
- JQC $5.65
- Technical
- Relative Strength Index (RSI)
- BCYC 34.58
- JQC 38.29
- Support Level
- BCYC $11.14
- JQC $5.47
- Resistance Level
- BCYC $13.11
- JQC $5.57
- Average True Range (ATR)
- BCYC 0.69
- JQC 0.05
- MACD
- BCYC 0.08
- JQC 0.00
- Stochastic Oscillator
- BCYC 22.32
- JQC 32.14
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.